Treatment satisfaction in Type 2 diabetes patients starting once daily insulin detemir

被引：0
|
作者：
Smith, I. C. [1 ]
Hansen, J. B. [2 ]
机构：
[1] Novo Nordisk Ltd, Pricing & Hlth Econ Unit, Gatwick, W Sussex, England
[2] Novo Nordisk AS, Bagsvaerd, Denmark
来源：
DIABETIC MEDICINE | 2008年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P245
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine
    Bradley, C.
    Gilbride, C. J. B.
    DIABETES OBESITY & METABOLISM, 2008, 10 : 50 - 65
  • [42] Costs analysis of type 2 diabetes mellitus treatment with insulin glargine or detemir
    Alvarez Guisasola, F.
    Mauricio Puente, D.
    Garcia Coscolin, T.
    Betegon Nicolas, L.
    Rubio-Terres, C.
    AVANCES EN DIABETOLOGIA, 2010, 26 (06): : 430 - 435
  • [43] Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients
    Jakobsen, Marie
    Dalsgaard, Mette
    Hormann, Morten
    Moller, Daniel Vega
    BMC ENDOCRINE DISORDERS, 2012, 12
  • [44] Comparison of Insulin Detemir and Insulin Glargine on Glycemic Variability in Patients with Type 1 and Type 2 Diabetes
    Tone, A.
    Iseda, I.
    Higuchi, C.
    Tsukamoto, K.
    Katayama, A.
    Matsushita, Y.
    Hida, K.
    Wada, J.
    Shikata, K.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (05) : 320 - 324
  • [45] Comparison of effects of insulin aspart three times a day versus insulin detemir once a day on oxidative stress in patients with type 2 diabetes
    Naruse, Rika
    Takebayashi, Kohzo
    Morita, Kimio
    Aso, Yoshimasa
    Inukai, Toshihiko
    ENDOCRINE JOURNAL, 2011, 58 (12) : 1055 - 1063
  • [46] Retrospective case-control study comparing twice daily insulin glargine and insulin detemir in veteran patients with type 2 diabetes
    Harmon, Timothy
    Worrall, Thomas J.
    PHARMACOTHERAPY, 2013, 33 (10): : E184 - E184
  • [47] Comparative study of annual treatment costs of glargine insulin and detemir insulin in patients with type 2 diabetes mellitus in Spain
    Alvarez Guisasola, F.
    Casal LLorente, C.
    Rubio-Terrés, C.
    Betegon, L.
    Echevarria, A.
    VALUE IN HEALTH, 2007, 10 (06) : A267 - A267
  • [48] Effect of insulin detemir on adipocyte lipid metabolism in patients with type 2 diabetes
    Alsini, N.
    Shojaee-Moradie, F.
    Sheldon, B.
    Robertson, M. D.
    Russell-Jones, D. L.
    Umpleby, A. M.
    Wright, J.
    DIABETOLOGIA, 2011, 54 : S236 - S237
  • [49] COMPARATIVE STUDY OF ANNUAL TREATMENT COST OF GLARGINE INSULIN AND DETEMIR INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN MEXICO
    Reyes-Lopez, A.
    Lemus, A.
    Sil, M. J. S. A.
    Acevedo, G. A. R.
    VALUE IN HEALTH, 2009, 12 (07) : A507 - A507
  • [50] Starting insulin therapy in type 2 diabetes: Twice-daily biphasic insulin aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride
    Kann, P. H.
    Wascher, T.
    Zackova, V.
    Moeller, J.
    Medding, J.
    Szocs, A.
    Mokan, M.
    Mrevlje, F.
    Regulski, M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (09) : 527 - 532
12345